Development and Evaluation of Virtual Reality Experiences for Cognitive Stimulation at the Sociosanitary Center El Carme
RTCSSC
Desarrollo y evaluación de Experiencias en Realidad Virtual Para la estimulación Cognitiva en el Centro Sociosanitario El Carme de Badalona Servicios Asistenciales (BSA)
1 other identifier
interventional
45
1 country
1
Brief Summary
The goal of this clinical trial is to test a virtual reality (VR)-based program designed for cognitive stimulation in individuals attending the conventional cognitive rehabilitation program at the Day Hospital of CSSC (Centro Sociosanitario El Carme) in Badalona, Spain. The trial will specifically assess VR's impact on declarative memory and executive functions through interactive exercises, as well as attention and episodic memory through VR video stimuli. The main questions it aims to answer are:
- Will patients with mild cognitive impairment find the VR program enjoyable and easy to use?
- Can VR interventions help improve patients' cognitive functions, specifically attention and memory?
- Do healthcare professionals find VR a practical tool for cognitive stimulation in their clinical practice? Participants will undergo a series of 8 sessions, scheduled twice a week to coincide with the conventional rehabilitation appointments. The VR equipment used will be Oculus Quest 2 headsets, offering an immersive experience with hand-tracking technology that simplifies interactions, particularly beneficial for those with mild cognitive impairment (MCI). During the study, participants will:
- Engage with a VR-based cognitive stimulation program.
- Undergo assessments of the participants´ cognitive functions before and after the intervention.
- Provide feedback on the participants´ experience with the VR program. Researchers will analyze the data to see if:
- The VR program leads to noticeable improvements in the cognitive abilities of participants.
- The program is well-received and deemed beneficial by both patients and healthcare professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2023
CompletedFirst Submitted
Initial submission to the registry
November 3, 2023
CompletedFirst Posted
Study publicly available on registry
December 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2024
CompletedResults Posted
Study results publicly available
March 25, 2025
CompletedMay 23, 2025
May 1, 2025
4 months
November 3, 2023
October 7, 2024
May 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Usability of VR Exercises as Measured by an Adapted 8-Item System Usability Scale (SUS)
Adapted 8-Item System Usability Scale (SUS): Score Range: 0 to 100 points Interpretation: Higher scores indicate better usability.
immediately post-intervention, within 30 minutes after the last intervention session- 8th session (day 8)
Comfort of VR Headset as Measured by an 8-Item SUS:
Adapted 8-Item VR Headset Comfort Rating: Score Range: 0 to 100 points Interpretation: Lower scores indicate better comfort (as most items measure discomfort).
immediately post-intervention, within 30 minutes after the 8th session (day 8)
Secondary Outcomes (9)
Professional´s Usability of VR Exercises as Measured by an Adapted 8-Item SUS:
Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
VR Headset Comfort Rating for Professionals as Measured by an Adapted 3-Item SUS:
immediately post-intervention, within 30 minutes after the 8th session (day 8)
Global Cognition as Measured by the Mini-Mental State Examination (MMSE)
Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Global Cognition as Measured by the Montreal Cognitive Assessment (MoCA)
Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
Short-Term Memory as Measured by the Digit Span Test (DST Forward Span)
Baseline and immediately post-intervention, within 30 minutes after the 8th session (day 8)
- +4 more secondary outcomes
Other Outcomes (2)
Demographics Variables
Baseline
Demographics Variables
Baseline
Study Arms (1)
Virtual Reality Cognitive Stimulation Program
EXPERIMENTALParticipants with MCI undergo 8 VR sessions, using Oculus Quest 2 headsets for immersive cognitive exercises. Activities include a Supermarket Shopping Task for memory, a Payment Task for cognitive flexibility, and a Recipe Sequencing Task for problem-solving. Additionally, 360-degree videos with visuo-verbal stimulation are used to engage attention and episodic memory, monitored by therapists. The investigators employ Oculus Quest 2 VR headsets with hand tracking technology to provide a seamless and immersive experience, especially beneficial for participants with Mild Cognitive Impairment (MCI).
Interventions
Intervention Type: Device Intervention Name: Virtual Reality Cognitive Stimulation Program Description: This program utilizes virtual reality to conduct cognitive stimulation exercises aimed at improving memory, executive functions, and attention in individuals with Mild Cognitive Impairment (MCI). It includes interactive tasks such as virtual shopping, payment simulations, and recipe sequencing, along with 360-degree video sessions for attention and episodic memory training.
Eligibility Criteria
You may qualify if:
- Participants must be classified as having mild cognitive impairment with a Mini-Mental State Examination (MMSE) score greater than 23.
- Participants must be currently attending cognitive rehabilitation sessions at the Day Hospital of the Centro Sociosanitario El Carme (CSSC).
- Participants must be able to give informed consent or, in the case of incapacity, consent must be obtained from their legal representative.
You may not qualify if:
- Patients with a severe or unstable illness that could interfere with participation in the study.
- Patients with serious psychiatric disorders, such as psychotic disorders, delusions, or hallucinations that may be exacerbated by the use of virtual reality.
- Patients with severe visual limitations that would prevent the use of virtual reality.
- Presence of ocular diseases causing blurred vision that cannot be corrected with contact lenses or glasses.
- Presence of auditory pathologies that cause a significant decrease in hearing without hearing aids.
- High sensitivity to motion sickness.
- Subjects with epilepsy.
- Patients who are unable or unwilling to give informed consent.
- Withdrawal Criteria
- The emergence of health problems that could interfere with the continuity of participation in the study, or the withdrawal of consent by the participant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Badalona Serveis Assistencialslead
- Public Health Agency of Barcelonacollaborator
- Reality Telling SLcollaborator
Study Sites (1)
Centro Socio Sanitario El Carmen
Badalona, Barcelona, 08917, Spain
Related Publications (8)
Bauer ACM, Andringa G. The Potential of Immersive Virtual Reality for Cognitive Training in Elderly. Gerontology. 2020;66(6):614-623. doi: 10.1159/000509830. Epub 2020 Sep 9.
PMID: 32906122BACKGROUNDLiao YY, Chen IH, Lin YJ, Chen Y, Hsu WC. Effects of Virtual Reality-Based Physical and Cognitive Training on Executive Function and Dual-Task Gait Performance in Older Adults With Mild Cognitive Impairment: A Randomized Control Trial. Front Aging Neurosci. 2019 Jul 16;11:162. doi: 10.3389/fnagi.2019.00162. eCollection 2019.
PMID: 31379553BACKGROUNDGomez-Caceres B, Cano-Lopez I, Alino M, Puig-Perez S. Effectiveness of virtual reality-based neuropsychological interventions in improving cognitive functioning in patients with mild cognitive impairment: A systematic review and meta-analysis. Clin Neuropsychol. 2023 Oct;37(7):1337-1370. doi: 10.1080/13854046.2022.2148283. Epub 2022 Nov 23.
PMID: 36416175BACKGROUNDMunoz J, Mehrabi S, Li Y, Basharat A, Middleton LE, Cao S, Barnett-Cowan M, Boger J. Immersive Virtual Reality Exergames for Persons Living With Dementia: User-Centered Design Study as a Multistakeholder Team During the COVID-19 Pandemic. JMIR Serious Games. 2022 Jan 19;10(1):e29987. doi: 10.2196/29987.
PMID: 35044320BACKGROUNDPapaioannou T, Voinescu A, Petrini K, Stanton Fraser D. Efficacy and Moderators of Virtual Reality for Cognitive Training in People with Dementia and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2022;88(4):1341-1370. doi: 10.3233/JAD-210672.
PMID: 35811514BACKGROUNDPerra A, Riccardo CL, De Lorenzo V, De Marco E, Di Natale L, Kurotschka PK, Preti A, Carta MG. Fully Immersive Virtual Reality-Based Cognitive Remediation for Adults with Psychosocial Disabilities: A Systematic Scoping Review of Methods Intervention Gaps and Meta-Analysis of Published Effectiveness Studies. Int J Environ Res Public Health. 2023 Jan 14;20(2):1527. doi: 10.3390/ijerph20021527.
PMID: 36674283BACKGROUNDQiu R, Gu Y, Xie C, Wang Y, Sheng Y, Zhu J, Yue Y, Cao J. Virtual reality-based targeted cognitive training program for Chinese older adults: A feasibility study. Geriatr Nurs. 2022 Sep-Oct;47:35-41. doi: 10.1016/j.gerinurse.2022.06.007. Epub 2022 Jul 12.
PMID: 35839753BACKGROUNDZuschnegg J, Schoberer D, Haussl A, Herzog SA, Russegger S, Ploder K, Fellner M, Hofmarcher-Holzhacker MM, Roller-Wirnsberger R, Paletta L, Koini M, Schussler S. Effectiveness of computer-based interventions for community-dwelling people with cognitive decline: a systematic review with meta-analyses. BMC Geriatr. 2023 Apr 12;23(1):229. doi: 10.1186/s12877-023-03941-y.
PMID: 37041494BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jose Ferrer Costa
- Organization
- Badalona Serveis Assistencials
Study Officials
- PRINCIPAL INVESTIGATOR
Jose Ferrer Costa, MD
Medical Researcher and Project Manager
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- No masking was involved in this study as all participants received the same intervention (the cognitive stimulation program using virtual reality created in collaboration with Reality Telling SL), and the open-label nature of the intervention made it impractical to blind participants or researchers to the treatment being provided.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 3, 2023
First Posted
December 4, 2023
Study Start
October 30, 2023
Primary Completion
February 27, 2024
Study Completion
March 27, 2024
Last Updated
May 23, 2025
Results First Posted
March 25, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Not applicable; individual participant data will not be shared.